Article
15 Aug 2025
FDA In Flux — August 2025 Newsletter
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
25 Jul 2025
FDA Warning Letter Reminds Industry That Wellness Claims Only Go So Far, Other Features Can Establish Intended Use
Article
15 Jul 2025
FDA In Flux — July 2025 Newsletter
Article
14 Jul 2025
Health Law Diagnosed – Best Practices For Communicating With The FDA (Podcast)
Article
23 Jun 2025
DOJ Civil Division Publishes Memo Outlining Trump Administration Civil Enforcement Priority Related To Health Care
Article
13 Jun 2025
FDA In Flux — June 2025 Newsletter
Article
02 Jun 2025
HHS Restructuring And Workforce Reductions
Article
16 May 2025
Twenty States Sue The Trump Administration For HHS Program Eliminations And Staff Layoffs
Article
08 May 2025
White House Budget Documents Provide Additional Insights Into The Trump Administration's Priorities For HHS
Article
06 May 2025
Deregulatory Push By Trump Administration Picks Up Speed
Article
21 Apr 2025
Regulation, Enforcement, And Associated Challenges Of The ENDS Industry: Part II
Article
16 Apr 2025
HHS Restructuring And Workforce Reductions – Key Implications For The Health Care Industry
Article
16 Apr 2025
Regulation, Enforcement, And Associated Challenges Of The ENDS Industry: Part I
Article
15 Apr 2025
A Texas Federal Court Sides With Laboratories, But There May Be Unintended Consequences For FDA
Article
17 Mar 2025
FDA's Backup LDT Enforcement Method: Specimen Collection Kits
Article
26 Feb 2025
FDA Continues Push To Improve Food Labeling Practices In The United States
Article
26 Dec 2024
Preparation For 2024 Fiscal Year-End SEC Filings And 2025 Annual Shareholder Meetings
Article
06 Sep 2024
FDA Continues To Intentionally Incorporate AI Into Medical Product Development With Its Establishment Of A New Internal Advisory Body
Article
20 Aug 2024
CMS Issues Final Notice On Program For Breakthrough Device Reimbursement But Industry Looks To Congress For More Inclusive Solution
Article
16 Aug 2024
FDA Rolls Out Innovative New Designation Programs In Response To Congressional Mandates